Xiaoxia Niu

Title: Innovations of Xiaoxia Niu in Genetic Engineering

Introduction

Xiaoxia Niu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of genetic engineering, particularly in the development of innovative medical compositions. His work has led to the creation of patents that enhance antiviral treatments.

Latest Patents

Xiaoxia Niu holds two notable patents, including the invention of interferon alpha mutants and their polyethylene glycol derivatives. These mutants are created by substituting Cys for Tyr at positions 85 or 86 in existing interferon alpha. The polyethylene glycol derivatives exhibit high in vitro antiviral activity and a prolonged in vivo half-life. The preparation methods for these PEG derivatives and the medical compositions that include them have also been detailed in his patents. Test results indicate that these interferon alpha mutants are easy to prepare and possess high activity, with their polyethylene glycol derivatives demonstrating an extended lifetime in the body and a low clearance rate.

Career Highlights

Throughout his career, Xiaoxia Niu has worked with several companies, including Beijing Tri-prime Genetic Engineering Co., Ltd. and Beijing Bio-tech Development Co., Ltd. His experience in these organizations has contributed to his expertise in genetic engineering and patent development.

Collaborations

Xiaoxia Niu has collaborated with notable colleagues, including Jinyi Liu and Minyi Zhou. These partnerships have likely facilitated advancements in his research and innovations.

Conclusion

Xiaoxia Niu's contributions to genetic engineering and his innovative patents reflect his dedication to advancing medical science. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.